QNCX
Quince Therapeutics, Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$0.16
+$0.01
(+9.28%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $8.85M | EPS (ttm) | $-1.20 | Current Price | $0.16 |
| Enterprise Value | $-198.91K | Forward EPS | $-0.99 | Previous Close | $0.15 |
| P/E Ratio | - | ROA | -22.10% | 52W High | $4.55 |
| Forward P/E | -0.16 | ROE | -247.78% | 52W Low | $0.14 |
| PEG Ratio | - | Gross Margin | - | 50 Day Avg | $3.06 |
| P/S Ratio | - | Operating Margin | - | 200 Day Avg | $1.90 |
| P/B Ratio | 8.36 | Profit Margin | - | Volume | 5.04M |
| EV/EBITDA | 0.01 | Current Ratio | 1.12 | Avg Volume | 2.17M |
| EV/Sales | - | Quick Ratio | 1.05 | Beta | 1.24 |
| Employees | 36.00 | Debt/Equity | 1699.06 | Shares Outstanding | 55.68M |
| Sector | Healthcare | Total Debt | $17.99M | Float Shares | 46.50M |
| Industry | Biotechnology | Total Cash | $26.29M | Short Float | 6.92% |
| Optionable | Yes | Cash/Share | $0.47 | Short Ratio | 4.38 |
| Dividend Yield | - | Book Value/Share | $0.02 | % Held by Insiders | 9.33% |
| Target Price | $5.00 | Revenue (TTM) | - | % Held by Institutions | 25.56% |